fashion & beauty
Hair Care Tips
Skin Care Guide
fitness & exercise
Credit Card Promos
Atomoxetine HCl, first non-stimulant ADHD
medication now available in the Philippines
Atomoxetine HCl, a non-stimulant treatment for attention-deficit
hyperactivity disorder (ADHD), is now available in the Philippines. It is the
first and only non-stimulant approved for the treatment of ADHD in children,
adolescents and adults.
"Until recently, stimulants were the most effective medication for ADHD.
With Atomoxetine HCl, we are now able to offer parents and their children an
alternative to stimulant treatment," said Sandeep Gupta, president and
general manager of Eli Lilly (Philippines), Inc.
The U.S. Food and Drug Administration approved Atomoxetine HCl on November
26, 2002 for the treatment of ADHD in children, adolescents and adults. It
became available in the United States in January 2003. The medication is also
currently approved in the United Kingdom, Australia, Mexico, Argentina and other
Latin American countries.
Atomoxetine HCl is a selective norepinephrine reuptake inhibitor. Unlike
previous FDA-approved treatments for ADHD, Atomoxetine HCl is not a controlled
substance and is not a stimulant under the US Controlled Substances Act.
It is not known precisely how Atomoxetine HCl reduces ADHD symptoms, but
scientists believe it works by blocking or slowing reabsorption of
norepinephrine, a chemical in the brain considered important in regulating
attention, impulsivity and activity levels. This keeps more norepinphrine at
work in the spaces between neurons in the brain.
ADHD, historically known as Attention-Deficit Disorder (ADD), is a medical
condition that first appears in childhood. ADHD affects 3-7 percent of
school-age children and manifests itself in levels of attention, concentration,
activity, distractibility and impulsivity inappropriate to the child's age. Many
children with the disorder will continue to have symptoms in adulthood, although
the hyperactivity tends to decrease with age.
ADHD affect not only the patient, but also those involved in a patient's
life. Symptoms often are severe enough to interfered with daily life and may
affect a patient's ability to foster healthy relationships with others and
function productively, whether at school, home or in social situations.
Atomoxetine HCl is a prescription drug and individuals should consult their
physicians for further information regarding ADHD and its treatment.
Lilly, a leading innovation-driven corporation, is developing a growing
portfolio of first-in-class and best-in-class pharmaceutical products by
applying the latest research from its own worldwide laboratories and from
collaborations with eminent scientific organizations. Headquartered in
Indianapolis, Inc., Lilly provides answers - through medicines and information -
for some of the world's most urgent medical needs. Additional information about
Lilly is available at www.lilly.com.
# # #
Health, Fitness and Beauty - Tips, Products and
Buyer's guide to cosmetic supplies, makeup tips, fitness equipment, skin care
products, supplements and fashion accessories such as jewelry, bags, shoes,
fragrance and more. Your guide to shopping online.